Pituitary Apoplexy in a Non-Functioning PitNET After Cabergoline Use: Case Report and Review of the Literature. [PDF]
De Luca F +5 more
europepmc +1 more source
Giant Prolactinoma: Challenges in Management. [PDF]
Sharma S, Acharya M, Sherpa C.
europepmc +1 more source
SGLT2 inhibitor therapy in diabetic cats: first clinical experiences with non-ideal candidates. [PDF]
Vanneste A +4 more
europepmc +1 more source
Effects of cabergoline at zebrafish development
Laura Roesler Nery +4 more
openalex +1 more source
Hypersomatotropism and Hypercortisolism Caused by a Plurihormonal Pituitary Adenoma in a Dog. [PDF]
Soler Arias EA +3 more
europepmc +1 more source
Editorial: Recent advances in secondary diabetes and glucose intolerance. [PDF]
Abe I +3 more
europepmc +1 more source
Vitamin D Status Determines the Effect of Cabergoline on Sexual Function and Depressive Symptoms in Hyperprolactinemic Women. [PDF]
Krysiak R +4 more
europepmc +1 more source
Prolactin-inhibitor cabergoline hastened the mammary involution during drying-off in dairy cows
Marion Boutinaud +6 more
openalex +1 more source
Predictors of therapeutic failure in GH and prolactin co-secreting pituitary adenomas. [PDF]
Araujo-Castro M +43 more
europepmc +1 more source
Effectiveness of Medical Treatment on Survivability in Canine Cushing's Syndrome: A Systematic Review and Meta-Analysis. [PDF]
Shanlly S +5 more
europepmc +1 more source

